| 0 |
SKIN GRAFT NECROSIS |
1 |
0.2500 |
| 1 |
CARDIOLIPIN ANTIBODY |
2 |
0.0645 |
| 2 |
APPENDICOLITH |
16 |
0.0413 |
| 3 |
ANTACID THERAPY |
5 |
0.0385 |
| 4 |
SLEEP DISORDER THERAPY |
7 |
0.0354 |
| 5 |
BACTEROIDES INFECTION |
6 |
0.0230 |
| 6 |
ANALGESIC THERAPY |
6 |
0.0187 |
| 7 |
DRUG THERAPY |
6 |
0.0177 |
| 8 |
ANTICOAGULANT THERAPY |
5 |
0.0176 |
| 9 |
CONGENITAL HIATUS HERNIA |
4 |
0.0175 |
| 10 |
MALIGNANT MELANOMA STAGE 0 |
3 |
0.0144 |
| 11 |
EYELID TUMOUR |
1 |
0.0132 |
| 12 |
HEPATIC VEIN OCCLUSION |
2 |
0.0127 |
| 13 |
NASAL ODOUR |
2 |
0.0120 |
| 14 |
DEHISCENCE |
2 |
0.0106 |
| 15 |
FOREIGN BODY IN MOUTH |
1 |
0.0100 |
| 16 |
ILIUM FRACTURE |
2 |
0.0098 |
| 17 |
TACHYCARDIA INDUCED CARDIOMYOPATHY |
1 |
0.0093 |
| 18 |
GAMMA-GLUTAMYLTRANSFERASE |
1 |
0.0092 |
| 19 |
CLOSTRIDIUM DIFFICILE SEPSIS |
1 |
0.0089 |
| 20 |
GASTROINTESTINAL DYSPLASIA |
1 |
0.0083 |
| 21 |
VOCAL CORD POLYP |
2 |
0.0071 |
| 22 |
ALLERGIC TRANSFUSION REACTION |
1 |
0.0066 |
| 23 |
TRACHEAL FISTULA |
1 |
0.0065 |
| 24 |
ANTINUCLEAR ANTIBODY |
1 |
0.0063 |
| 25 |
VENTRICULAR ENLARGEMENT |
1 |
0.0057 |
| 26 |
SMALL INTESTINE ADENOCARCINOMA |
1 |
0.0056 |
| 27 |
HYPERPHOSPHATAEMIA |
12 |
0.0056 |
| 28 |
GAMMOPATHY |
1 |
0.0055 |
| 29 |
CARDIOLIPIN ANTIBODY POSITIVE |
1 |
0.0055 |
| 30 |
HEPATIC CONGESTION |
5 |
0.0053 |
| 31 |
BLOOD PHOSPHORUS INCREASED |
14 |
0.0051 |
| 32 |
STAPHYLOCOCCAL SCALDED SKIN SYNDROME |
1 |
0.0044 |
| 33 |
ALDOLASE INCREASED |
1 |
0.0044 |
| 34 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
4 |
0.0043 |
| 35 |
APPLICATION SITE BLEEDING |
1 |
0.0040 |
| 36 |
RECTAL NEOPLASM |
1 |
0.0038 |
| 37 |
CUTIS LAXA |
1 |
0.0037 |
| 38 |
SERONEGATIVE ARTHRITIS |
4 |
0.0035 |
| 39 |
BINOCULAR EYE MOVEMENT DISORDER |
1 |
0.0035 |
| 40 |
FACET JOINT SYNDROME |
11 |
0.0034 |
| 41 |
BLADDER TAMPONADE |
1 |
0.0033 |
| 42 |
MYXOEDEMA COMA |
1 |
0.0033 |
| 43 |
LUPUS VULGARIS |
4 |
0.0032 |
| 44 |
TOTAL LUNG CAPACITY DECREASED |
5 |
0.0031 |
| 45 |
ANTINUCLEAR ANTIBODY INCREASED |
3 |
0.0031 |
| 46 |
IRON DEFICIENCY |
14 |
0.0031 |
| 47 |
CELLULITIS STAPHYLOCOCCAL |
2 |
0.0031 |
| 48 |
DIABETIC HYPERGLYCAEMIC COMA |
1 |
0.0031 |
| 49 |
PENILE ULCERATION |
1 |
0.0031 |
| 50 |
RECTAL POLYP |
3 |
0.0030 |
| 51 |
SALIVA DISCOLOURATION |
1 |
0.0030 |
| 52 |
OVERLAP SYNDROME |
2 |
0.0029 |
| 53 |
HYPOCHOLESTEROLAEMIA |
1 |
0.0028 |
| 54 |
VAGINAL FISTULA |
1 |
0.0028 |
| 55 |
GASTROINTESTINAL TRACT ADENOMA |
1 |
0.0027 |
| 56 |
PERIPHERAL VENOUS DISEASE |
11 |
0.0027 |
| 57 |
BICYTOPENIA |
5 |
0.0025 |
| 58 |
SINONASAL OBSTRUCTION |
1 |
0.0025 |
| 59 |
SPHINCTER OF ODDI DYSFUNCTION |
1 |
0.0024 |
| 60 |
BLOOD URIC ACID INCREASED |
14 |
0.0024 |
| 61 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
5 |
0.0024 |
| 62 |
RETINITIS |
4 |
0.0023 |
| 63 |
AORTIC STENOSIS |
8 |
0.0023 |
| 64 |
DISLOCATION OF VERTEBRA |
5 |
0.0022 |
| 65 |
VEIN DISCOLOURATION |
1 |
0.0021 |
| 66 |
WOUND NECROSIS |
1 |
0.0021 |
| 67 |
RHEUMATOID FACTOR POSITIVE |
12 |
0.0021 |
| 68 |
SKIN FIBROSIS |
1 |
0.0021 |
| 69 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
4 |
0.0020 |
| 70 |
EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) |
1 |
0.0020 |
| 71 |
DERMATOMYOSITIS |
5 |
0.0020 |
| 72 |
JOINT DESTRUCTION |
3 |
0.0019 |
| 73 |
TRACHEAL DISORDER |
1 |
0.0019 |
| 74 |
SCAPULA FRACTURE |
1 |
0.0019 |
| 75 |
INTRAOCULAR PRESSURE DECREASED |
1 |
0.0019 |
| 76 |
HYPOPHOSPHATAEMIA |
14 |
0.0019 |
| 77 |
MYASTHENIA GRAVIS |
15 |
0.0019 |
| 78 |
BODY FAT DISORDER |
1 |
0.0018 |
| 79 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
1 |
0.0018 |
| 80 |
INTRACRANIAL HAEMATOMA |
1 |
0.0018 |
| 81 |
PNEUMONIA PRIMARY ATYPICAL |
1 |
0.0018 |
| 82 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
9 |
0.0018 |
| 83 |
ANTI FACTOR VIII ANTIBODY POSITIVE |
1 |
0.0018 |
| 84 |
RADIATION NECROSIS |
1 |
0.0017 |
| 85 |
APPENDICITIS |
16 |
0.0017 |
| 86 |
HUMAN HERPESVIRUS 8 INFECTION |
1 |
0.0016 |
| 87 |
OPEN ANGLE GLAUCOMA |
1 |
0.0016 |
| 88 |
SWOLLEN JOINT COUNT INCREASED |
5 |
0.0016 |
| 89 |
LYMPHADENOPATHY MEDIASTINAL |
3 |
0.0016 |
| 90 |
HYPERCHLORAEMIA |
1 |
0.0016 |
| 91 |
C-REACTIVE PROTEIN ABNORMAL |
10 |
0.0016 |
| 92 |
REFLEXES ABNORMAL |
1 |
0.0015 |
| 93 |
SCLERAL DISCOLOURATION |
1 |
0.0015 |
| 94 |
LUNG OPACITY |
4 |
0.0015 |
| 95 |
DUODENAL ULCER PERFORATION |
11 |
0.0015 |
| 96 |
GENITAL SWELLING |
1 |
0.0014 |
| 97 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
10 |
0.0014 |
| 98 |
VENTRICULAR FIBRILLATION |
15 |
0.0013 |
| 99 |
ILEUS PARALYTIC |
6 |
0.0013 |
| 100 |
MUSCLE INJURY |
11 |
0.0013 |
| 101 |
NASAL ULCER |
2 |
0.0013 |
| 102 |
GOUTY ARTHRITIS |
1 |
0.0013 |
| 103 |
LYMPHOCYTE STIMULATION TEST POSITIVE |
1 |
0.0012 |
| 104 |
BARRETT'S OESOPHAGUS |
1 |
0.0012 |
| 105 |
ENTEROCOCCAL SEPSIS |
1 |
0.0012 |
| 106 |
BRONCHITIS CHRONIC |
3 |
0.0012 |
| 107 |
ACNE PUSTULAR |
1 |
0.0012 |
| 108 |
LIP DRY |
11 |
0.0012 |
| 109 |
FUNGAL SEPSIS |
1 |
0.0012 |
| 110 |
DEVELOPMENTAL HIP DYSPLASIA |
1 |
0.0012 |
| 111 |
TACHYARRHYTHMIA |
3 |
0.0012 |
| 112 |
ADENOMA BENIGN |
1 |
0.0012 |
| 113 |
BENIGN PROSTATIC HYPERPLASIA |
6 |
0.0012 |
| 114 |
GASTROINTESTINAL NEOPLASM |
1 |
0.0012 |
| 115 |
BONE EROSION |
4 |
0.0011 |
| 116 |
CYTOMEGALOVIRUS TEST POSITIVE |
2 |
0.0011 |
| 117 |
RHEUMATIC FEVER |
5 |
0.0011 |
| 118 |
CANDIDA SEPSIS |
1 |
0.0011 |
| 119 |
MUCOSAL EROSION |
1 |
0.0011 |
| 120 |
C-REACTIVE PROTEIN |
1 |
0.0011 |
| 121 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
18 |
0.0010 |
| 122 |
FOLLICULITIS |
11 |
0.0010 |
| 123 |
COLON NEOPLASM |
1 |
0.0010 |
| 124 |
LYMPHOCYTIC INFILTRATION |
1 |
0.0010 |
| 125 |
DILATED CARDIOMYOPATHY |
1 |
0.0010 |
| 126 |
SPINAL FUSION SURGERY |
4 |
0.0010 |
| 127 |
TRIGGER FINGER |
4 |
0.0010 |
| 128 |
CARDIOGENIC SHOCK |
14 |
0.0010 |
| 129 |
HELICOBACTER INFECTION |
10 |
0.0010 |
| 130 |
POSTICTAL STATE |
1 |
0.0010 |
| 131 |
RESPIRATORY TRACT IRRITATION |
1 |
0.0010 |
| 132 |
JOINT CONTRACTURE |
1 |
0.0009 |
| 133 |
TROPONIN INCREASED |
7 |
0.0009 |
| 134 |
ACARODERMATITIS |
1 |
0.0009 |
| 135 |
BURSITIS |
11 |
0.0009 |
| 136 |
ESSENTIAL TREMOR |
1 |
0.0009 |
| 137 |
PEMPHIGUS |
11 |
0.0009 |
| 138 |
ACUTE PRERENAL FAILURE |
1 |
0.0009 |
| 139 |
HAND DEFORMITY |
11 |
0.0008 |
| 140 |
UPPER RESPIRATORY TRACT INFLAMMATION |
1 |
0.0008 |
| 141 |
JOINT RANGE OF MOTION DECREASED |
11 |
0.0008 |
| 142 |
ORAL MUCOSA EROSION |
1 |
0.0008 |
| 143 |
XEROSIS |
1 |
0.0008 |
| 144 |
MALIGNANT MELANOMA IN SITU |
1 |
0.0008 |
| 145 |
ASPERGILLOSIS |
1 |
0.0008 |
| 146 |
NON-HODGKIN'S LYMPHOMA |
1 |
0.0008 |
| 147 |
WALKING AID USER |
5 |
0.0008 |
| 148 |
CARBON DIOXIDE INCREASED |
1 |
0.0007 |
| 149 |
PLEURITIC PAIN |
2 |
0.0007 |
| 150 |
SYNOVITIS |
13 |
0.0007 |
| 151 |
RESPIRATORY SYMPTOM |
2 |
0.0007 |
| 152 |
IRRITABLE BOWEL SYNDROME |
15 |
0.0007 |
| 153 |
PORPHYRIA ACUTE |
1 |
0.0007 |
| 154 |
OBESITY |
11 |
0.0007 |
| 155 |
ADENOVIRUS INFECTION |
2 |
0.0007 |
| 156 |
DIVERTICULUM INTESTINAL |
3 |
0.0007 |
| 157 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
0.0007 |
| 158 |
ASCITES |
20 |
0.0007 |
| 159 |
GROWTH RETARDATION |
2 |
0.0007 |
| 160 |
ATYPICAL PNEUMONIA |
2 |
0.0007 |
| 161 |
LUPUS-LIKE SYNDROME |
6 |
0.0007 |
| 162 |
FIBROMYALGIA |
16 |
0.0007 |
| 163 |
NEURALGIA |
16 |
0.0007 |
| 164 |
PNEUMONIA PSEUDOMONAL |
1 |
0.0007 |
| 165 |
ACCIDENTAL DRUG INTAKE BY CHILD |
1 |
0.0007 |
| 166 |
ULCER |
10 |
0.0006 |
| 167 |
PNEUMONIA LEGIONELLA |
1 |
0.0006 |
| 168 |
OVARIAN CANCER RECURRENT |
1 |
0.0006 |
| 169 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
2 |
0.0006 |
| 170 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
4 |
0.0006 |
| 171 |
METABOLIC SYNDROME |
1 |
0.0006 |
| 172 |
STAPHYLOCOCCAL SEPSIS |
3 |
0.0006 |
| 173 |
MYOCARDIAL NECROSIS MARKER INCREASED |
1 |
0.0006 |
| 174 |
PERICARDITIS |
10 |
0.0006 |
| 175 |
ULCER HAEMORRHAGE |
4 |
0.0006 |
| 176 |
BACTERIAL INFECTION |
11 |
0.0006 |
| 177 |
GAZE PALSY |
1 |
0.0006 |
| 178 |
HYPERLIPIDAEMIA |
7 |
0.0006 |
| 179 |
FEMALE GENITAL TRACT FISTULA |
1 |
0.0006 |
| 180 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 181 |
BLOOD CALCIUM INCREASED |
5 |
0.0006 |
| 182 |
POLYARTHRITIS |
3 |
0.0006 |
| 183 |
GRIP STRENGTH DECREASED |
5 |
0.0006 |
| 184 |
PARAPARESIS |
1 |
0.0006 |
| 185 |
AORTIC VALVE STENOSIS |
1 |
0.0006 |
| 186 |
X-RAY ABNORMAL |
1 |
0.0006 |
| 187 |
SOFT TISSUE INFECTION |
1 |
0.0005 |
| 188 |
TRAUMATIC HAEMORRHAGE |
1 |
0.0005 |
| 189 |
HYPOPROTEINAEMIA |
1 |
0.0005 |
| 190 |
HYPERCHOLESTEROLAEMIA |
5 |
0.0005 |
| 191 |
TRAUMATIC LUNG INJURY |
1 |
0.0005 |
| 192 |
OCULAR HYPERTENSION |
1 |
0.0005 |
| 193 |
BLOOD CHOLESTEROL INCREASED |
24 |
0.0005 |
| 194 |
ABDOMINAL WALL HAEMATOMA |
1 |
0.0005 |
| 195 |
GOUT |
9 |
0.0005 |
| 196 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 197 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
14 |
0.0005 |
| 198 |
SPINAL STENOSIS |
2 |
0.0005 |
| 199 |
SKIN INDURATION |
1 |
0.0005 |
| 200 |
LUNG ABSCESS |
1 |
0.0005 |
| 201 |
URINARY BLADDER HAEMORRHAGE |
1 |
0.0005 |
| 202 |
LIVER FUNCTION TEST INCREASED |
10 |
0.0005 |
| 203 |
WOUND |
13 |
0.0005 |
| 204 |
POLYP |
3 |
0.0005 |
| 205 |
ASPIRATION |
5 |
0.0005 |
| 206 |
BACTERIAL TEST POSITIVE |
1 |
0.0004 |
| 207 |
LIVER INJURY |
11 |
0.0004 |
| 208 |
PSEUDOMEMBRANOUS COLITIS |
1 |
0.0004 |
| 209 |
GLOSSODYNIA |
10 |
0.0004 |
| 210 |
LARGE INTESTINAL HAEMORRHAGE |
1 |
0.0004 |
| 211 |
PNEUMOTHORAX |
7 |
0.0004 |
| 212 |
METASTASES TO MENINGES |
1 |
0.0004 |
| 213 |
EXOSTOSIS |
4 |
0.0004 |
| 214 |
METASTATIC MALIGNANT MELANOMA |
1 |
0.0004 |
| 215 |
HAEMOLYTIC URAEMIC SYNDROME |
1 |
0.0004 |
| 216 |
HEPATIC STEATOSIS |
8 |
0.0004 |
| 217 |
DISCOURAGEMENT |
1 |
0.0004 |
| 218 |
ESCHERICHIA BACTERAEMIA |
1 |
0.0004 |
| 219 |
SKIN TIGHTNESS |
2 |
0.0004 |
| 220 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 221 |
INTRA-ABDOMINAL HAEMORRHAGE |
1 |
0.0004 |
| 222 |
AUTOIMMUNE DISORDER |
4 |
0.0004 |
| 223 |
BREATH SOUNDS ABNORMAL |
2 |
0.0004 |
| 224 |
RETROPERITONEAL HAEMORRHAGE |
1 |
0.0004 |
| 225 |
SUFFOCATION FEELING |
1 |
0.0004 |
| 226 |
INFREQUENT BOWEL MOVEMENTS |
1 |
0.0004 |
| 227 |
HYPERNATRAEMIA |
2 |
0.0004 |
| 228 |
VENOOCCLUSIVE DISEASE |
1 |
0.0004 |
| 229 |
END STAGE RENAL DISEASE |
7 |
0.0004 |
| 230 |
NODULE |
5 |
0.0004 |
| 231 |
URINE OUTPUT INCREASED |
1 |
0.0004 |
| 232 |
JOINT DISLOCATION |
4 |
0.0004 |
| 233 |
SCIATICA |
6 |
0.0004 |
| 234 |
NASAL DISORDER |
1 |
0.0004 |
| 235 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 236 |
LOWER RESPIRATORY TRACT INFECTION |
17 |
0.0004 |
| 237 |
NIGHT SWEATS |
12 |
0.0004 |
| 238 |
PULMONARY FIBROSIS |
7 |
0.0004 |
| 239 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
4 |
0.0004 |
| 240 |
FOOT DEFORMITY |
4 |
0.0004 |
| 241 |
CHOLECYSTITIS INFECTIVE |
1 |
0.0004 |
| 242 |
LIVE BIRTH |
3 |
0.0004 |
| 243 |
DRY MOUTH |
29 |
0.0004 |
| 244 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 245 |
BLOOD TEST ABNORMAL |
5 |
0.0004 |
| 246 |
SKIN HYPERTROPHY |
1 |
0.0004 |
| 247 |
FORCED EXPIRATORY VOLUME DECREASED |
1 |
0.0004 |
| 248 |
GENERALISED ERYTHEMA |
2 |
0.0004 |
| 249 |
HYPOGLYCAEMIC COMA |
1 |
0.0003 |
| 250 |
GENERAL PHYSICAL HEALTH DETERIORATION |
40 |
0.0003 |
| 251 |
DYSPNOEA AT REST |
1 |
0.0003 |
| 252 |
RALES |
2 |
0.0003 |
| 253 |
GASTROINTESTINAL NECROSIS |
1 |
0.0003 |
| 254 |
SPINAL OSTEOARTHRITIS |
3 |
0.0003 |
| 255 |
CARDIOMYOPATHY |
5 |
0.0003 |
| 256 |
IMPAIRED HEALING |
11 |
0.0003 |
| 257 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 258 |
GANGRENE |
2 |
0.0003 |
| 259 |
NEPHROGENIC SYSTEMIC FIBROSIS |
1 |
0.0003 |
| 260 |
TOXIC EPIDERMAL NECROLYSIS |
5 |
0.0003 |
| 261 |
EYE INJURY |
1 |
0.0003 |
| 262 |
BLEPHAROSPASM |
2 |
0.0003 |
| 263 |
ABDOMINAL ADHESIONS |
1 |
0.0003 |
| 264 |
SLEEP DISORDER |
22 |
0.0003 |
| 265 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
11 |
0.0003 |
| 266 |
BREAST CANCER STAGE III |
2 |
0.0003 |
| 267 |
ASPERGILLUS INFECTION |
2 |
0.0003 |
| 268 |
SKIN INJURY |
1 |
0.0003 |
| 269 |
CARDIAC FAILURE ACUTE |
2 |
0.0003 |
| 270 |
BREAST MASS |
2 |
0.0003 |
| 271 |
BRONCHIECTASIS |
2 |
0.0003 |
| 272 |
STOMATITIS |
18 |
0.0003 |
| 273 |
CLOSTRIDIAL INFECTION |
1 |
0.0003 |
| 274 |
OEDEMA |
16 |
0.0003 |
| 275 |
B-CELL LYMPHOMA |
1 |
0.0003 |
| 276 |
PUSTULAR PSORIASIS |
1 |
0.0003 |
| 277 |
PETECHIAE |
3 |
0.0003 |
| 278 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
15 |
0.0003 |
| 279 |
APHONIA |
4 |
0.0003 |
| 280 |
LUNG DISORDER |
14 |
0.0003 |
| 281 |
CARPAL TUNNEL SYNDROME |
4 |
0.0003 |
| 282 |
DISSEMINATED INTRAVASCULAR COAGULATION |
4 |
0.0003 |
| 283 |
HYPONATRAEMIA |
16 |
0.0003 |
| 284 |
DEPRESSIVE SYMPTOM |
1 |
0.0003 |
| 285 |
GRAFT VERSUS HOST DISEASE |
2 |
0.0003 |
| 286 |
PYODERMA GANGRENOSUM |
1 |
0.0003 |
| 287 |
SWELLING |
26 |
0.0003 |
| 288 |
FACIAL BONES FRACTURE |
1 |
0.0003 |
| 289 |
PSORIATIC ARTHROPATHY |
11 |
0.0003 |
| 290 |
AMYLASE INCREASED |
1 |
0.0003 |
| 291 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0003 |
| 292 |
NERVE INJURY |
3 |
0.0003 |
| 293 |
OBSTRUCTIVE AIRWAYS DISORDER |
3 |
0.0003 |
| 294 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 295 |
LEUKOENCEPHALOPATHY |
1 |
0.0003 |
| 296 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0003 |
| 297 |
MICTURITION URGENCY |
3 |
0.0003 |
| 298 |
SLEEP APNOEA SYNDROME |
5 |
0.0003 |
| 299 |
HIP ARTHROPLASTY |
4 |
0.0003 |
| 300 |
OSTEOARTHRITIS |
11 |
0.0003 |
| 301 |
PRESCRIBED OVERDOSE |
5 |
0.0003 |
| 302 |
TENDONITIS |
4 |
0.0003 |
| 303 |
ELECTROLYTE IMBALANCE |
3 |
0.0003 |
| 304 |
FAECES HARD |
1 |
0.0003 |
| 305 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 306 |
OESOPHAGEAL PAIN |
1 |
0.0003 |
| 307 |
POLYDIPSIA |
1 |
0.0003 |
| 308 |
WHEEZING |
15 |
0.0003 |
| 309 |
HYPERPHAGIA |
1 |
0.0003 |
| 310 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 311 |
DECUBITUS ULCER |
2 |
0.0002 |
| 312 |
GOITRE |
1 |
0.0002 |
| 313 |
HYPERURICAEMIA |
1 |
0.0002 |
| 314 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 315 |
SPINAL COMPRESSION FRACTURE |
2 |
0.0002 |
| 316 |
ILEUS |
3 |
0.0002 |
| 317 |
ONYCHOMADESIS |
1 |
0.0002 |
| 318 |
BUNDLE BRANCH BLOCK LEFT |
1 |
0.0002 |
| 319 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 320 |
ANOREXIA |
3 |
0.0002 |
| 321 |
HIATUS HERNIA |
3 |
0.0002 |
| 322 |
PLEURAL EFFUSION |
14 |
0.0002 |
| 323 |
EPILEPSY |
7 |
0.0002 |
| 324 |
JOINT STIFFNESS |
6 |
0.0002 |
| 325 |
MUSCULOSKELETAL STIFFNESS |
20 |
0.0002 |
| 326 |
ONYCHOMYCOSIS |
1 |
0.0002 |
| 327 |
TUMOUR LYSIS SYNDROME |
2 |
0.0002 |
| 328 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 329 |
OVARIAN CANCER |
2 |
0.0002 |
| 330 |
IRON DEFICIENCY ANAEMIA |
2 |
0.0002 |
| 331 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 332 |
HAEMOPTYSIS |
6 |
0.0002 |
| 333 |
GASTRITIS EROSIVE |
1 |
0.0002 |
| 334 |
BLISTER |
12 |
0.0002 |
| 335 |
INJURY |
15 |
0.0002 |
| 336 |
INFLAMMATION |
11 |
0.0002 |
| 337 |
HEPATIC CIRRHOSIS |
4 |
0.0002 |
| 338 |
SPINAL COLUMN STENOSIS |
1 |
0.0002 |
| 339 |
SPUTUM DISCOLOURED |
2 |
0.0002 |
| 340 |
NON-SMALL CELL LUNG CANCER |
1 |
0.0002 |
| 341 |
LOWER LIMB FRACTURE |
4 |
0.0002 |
| 342 |
RASH VESICULAR |
1 |
0.0002 |
| 343 |
FINGER DEFORMITY |
1 |
0.0002 |
| 344 |
INTENTIONAL PRODUCT MISUSE |
18 |
0.0002 |
| 345 |
THROMBOTIC MICROANGIOPATHY |
2 |
0.0002 |
| 346 |
HAEMORRHOIDAL HAEMORRHAGE |
1 |
0.0002 |
| 347 |
DISABILITY |
4 |
0.0002 |
| 348 |
DELIRIUM |
7 |
0.0002 |
| 349 |
PULMONARY MASS |
3 |
0.0002 |
| 350 |
IMMUNODEFICIENCY |
3 |
0.0002 |
| 351 |
INJECTION SITE INFLAMMATION |
1 |
0.0002 |
| 352 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 353 |
PRESCRIBED UNDERDOSE |
4 |
0.0002 |
| 354 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 355 |
TOXIC SKIN ERUPTION |
2 |
0.0002 |
| 356 |
DRUG TOLERANCE |
1 |
0.0002 |
| 357 |
SEPSIS |
22 |
0.0002 |
| 358 |
DIABETES MELLITUS |
15 |
0.0002 |
| 359 |
BODY TEMPERATURE INCREASED |
4 |
0.0002 |
| 360 |
ENDOCARDITIS |
1 |
0.0002 |
| 361 |
UNRESPONSIVE TO STIMULI |
5 |
0.0002 |
| 362 |
VARICOSE VEIN |
1 |
0.0002 |
| 363 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 364 |
DRUG-INDUCED LIVER INJURY |
6 |
0.0002 |
| 365 |
MUSCULOSKELETAL PAIN |
10 |
0.0002 |
| 366 |
KNEE ARTHROPLASTY |
4 |
0.0002 |
| 367 |
FULL BLOOD COUNT ABNORMAL |
2 |
0.0002 |
| 368 |
JOINT INJURY |
4 |
0.0002 |
| 369 |
THROMBOSIS |
15 |
0.0002 |
| 370 |
DRUG INTOLERANCE |
18 |
0.0002 |
| 371 |
CHEILITIS |
1 |
0.0002 |
| 372 |
NORMAL NEWBORN |
1 |
0.0002 |
| 373 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 374 |
WOUND INFECTION |
2 |
0.0002 |
| 375 |
LEUKOPENIA |
9 |
0.0002 |
| 376 |
ARTHROPATHY |
10 |
0.0002 |
| 377 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 378 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
1 |
0.0002 |
| 379 |
HEPATIC ENZYME INCREASED |
12 |
0.0002 |
| 380 |
CHOLECYSTECTOMY |
2 |
0.0002 |
| 381 |
NEUROLOGICAL SYMPTOM |
1 |
0.0002 |
| 382 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 383 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
5 |
0.0002 |
| 384 |
UPPER RESPIRATORY TRACT INFECTION |
8 |
0.0002 |
| 385 |
ABDOMINAL DISTENSION |
18 |
0.0002 |
| 386 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 387 |
HYPERCHLORHYDRIA |
1 |
0.0002 |
| 388 |
BRADYCARDIA |
9 |
0.0002 |
| 389 |
RESPIRATORY DISORDER |
5 |
0.0002 |
| 390 |
CONTRAINDICATED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 391 |
INGUINAL HERNIA |
1 |
0.0002 |
| 392 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 393 |
OEDEMA PERIPHERAL |
20 |
0.0002 |
| 394 |
DISCOMFORT |
10 |
0.0002 |
| 395 |
SEPTIC SHOCK |
7 |
0.0002 |
| 396 |
PULMONARY EMBOLISM |
15 |
0.0002 |
| 397 |
MUSCULOSKELETAL DISORDER |
3 |
0.0002 |
| 398 |
ANAEMIA |
30 |
0.0002 |
| 399 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
2 |
0.0002 |
| 400 |
HAEMORRHOIDS |
3 |
0.0002 |
| 401 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 402 |
HYPOKALAEMIA |
7 |
0.0002 |
| 403 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 404 |
INFUSION RELATED REACTION |
10 |
0.0002 |
| 405 |
EAR INFECTION |
4 |
0.0002 |
| 406 |
SKIN MASS |
1 |
0.0001 |
| 407 |
CHOLECYSTITIS CHRONIC |
1 |
0.0001 |
| 408 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 409 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 410 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 411 |
NEPHROTIC SYNDROME |
1 |
0.0001 |
| 412 |
ECCHYMOSIS |
1 |
0.0001 |
| 413 |
LYMPHOEDEMA |
1 |
0.0001 |
| 414 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 415 |
SINUS TACHYCARDIA |
2 |
0.0001 |
| 416 |
FEAR OF INJECTION |
1 |
0.0001 |
| 417 |
ABDOMINAL PAIN |
32 |
0.0001 |
| 418 |
RESPIRATORY FAILURE |
10 |
0.0001 |
| 419 |
UTERINE LEIOMYOMA |
1 |
0.0001 |
| 420 |
LIVER DISORDER |
6 |
0.0001 |
| 421 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 422 |
SKIN HAEMORRHAGE |
2 |
0.0001 |
| 423 |
SUNBURN |
1 |
0.0001 |
| 424 |
HEPATIC FUNCTION ABNORMAL |
5 |
0.0001 |
| 425 |
GENERAL SYMPTOM |
1 |
0.0001 |
| 426 |
CARDIAC ARREST |
11 |
0.0001 |
| 427 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 428 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
2 |
0.0001 |
| 429 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 430 |
ABSCESS |
2 |
0.0001 |
| 431 |
RHINITIS |
1 |
0.0001 |
| 432 |
OSTEOPOROSIS |
5 |
0.0001 |
| 433 |
BLOOD PRESSURE DECREASED |
8 |
0.0001 |
| 434 |
BREAST CANCER STAGE II |
1 |
0.0001 |
| 435 |
PNEUMONIA ASPIRATION |
3 |
0.0001 |
| 436 |
GAIT INABILITY |
4 |
0.0001 |
| 437 |
TRANSIENT ISCHAEMIC ATTACK |
4 |
0.0001 |
| 438 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
| 439 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
3 |
0.0001 |
| 440 |
PSYCHOLOGICAL TRAUMA |
1 |
0.0001 |
| 441 |
HYSTERECTOMY |
1 |
0.0001 |
| 442 |
RHEUMATOID ARTHRITIS |
13 |
0.0001 |
| 443 |
NAIL DISORDER |
1 |
0.0001 |
| 444 |
GROIN PAIN |
1 |
0.0001 |
| 445 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 446 |
ASPARTATE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 447 |
CONDITION AGGRAVATED |
34 |
0.0001 |
| 448 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
5 |
0.0001 |
| 449 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 450 |
MYOSITIS |
1 |
0.0001 |
| 451 |
THROAT IRRITATION |
5 |
0.0001 |
| 452 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 453 |
PNEUMONITIS |
3 |
0.0001 |
| 454 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 455 |
HYPERSENSITIVITY |
20 |
0.0001 |
| 456 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 457 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 458 |
MIDDLE INSOMNIA |
2 |
0.0001 |
| 459 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 460 |
OXYGEN SATURATION DECREASED |
6 |
0.0001 |
| 461 |
LEUKAEMIA |
1 |
0.0001 |
| 462 |
HYPOCALCAEMIA |
2 |
0.0001 |
| 463 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 464 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 465 |
LIVER FUNCTION TEST ABNORMAL |
3 |
0.0001 |
| 466 |
COELIAC DISEASE |
1 |
0.0001 |
| 467 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 468 |
ABDOMINAL DISCOMFORT |
17 |
0.0001 |
| 469 |
TACHYCARDIA |
9 |
0.0001 |
| 470 |
HYPOTONIA |
1 |
0.0001 |
| 471 |
CORONARY ARTERY DISEASE |
3 |
0.0001 |
| 472 |
HYPOTHERMIA |
1 |
0.0001 |
| 473 |
TASTE DISORDER |
2 |
0.0001 |
| 474 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 475 |
NEUTROPHIL COUNT DECREASED |
4 |
0.0001 |
| 476 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 477 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 478 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 479 |
INFECTION |
14 |
0.0001 |
| 480 |
SKELETAL INJURY |
1 |
0.0001 |
| 481 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 482 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 483 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 484 |
INTENTIONAL DRUG MISUSE |
2 |
0.0001 |
| 485 |
ROAD TRAFFIC ACCIDENT |
4 |
0.0001 |
| 486 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 487 |
INCONTINENCE |
1 |
0.0001 |
| 488 |
BRONCHITIS |
7 |
0.0001 |
| 489 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 490 |
PYREXIA |
32 |
0.0001 |
| 491 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 492 |
BACK INJURY |
1 |
0.0001 |
| 493 |
CONSTIPATION |
20 |
0.0001 |
| 494 |
CHOLELITHIASIS |
3 |
0.0001 |
| 495 |
JOINT SWELLING |
11 |
0.0001 |
| 496 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 497 |
HAEMATOCHEZIA |
5 |
0.0001 |
| 498 |
FEBRILE NEUTROPENIA |
6 |
0.0001 |
| 499 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 500 |
SKIN DISORDER |
3 |
0.0001 |
| 501 |
SOMNOLENCE |
18 |
0.0001 |
| 502 |
GASTROINTESTINAL DISORDER |
8 |
0.0001 |
| 503 |
TYPE 2 DIABETES MELLITUS |
3 |
0.0001 |
| 504 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 505 |
THERAPY NON-RESPONDER |
4 |
0.0001 |
| 506 |
FISTULA |
1 |
0.0001 |
| 507 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 508 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 509 |
MYOCARDITIS |
1 |
0.0001 |
| 510 |
GASTROOESOPHAGEAL REFLUX DISEASE |
7 |
0.0001 |
| 511 |
ALOPECIA |
17 |
0.0001 |
| 512 |
METASTASES TO LUNG |
1 |
0.0001 |
| 513 |
EYELID OEDEMA |
1 |
0.0001 |
| 514 |
PERIPHERAL SWELLING |
13 |
0.0001 |
| 515 |
BACTERAEMIA |
1 |
0.0001 |
| 516 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 517 |
PNEUMONIA |
27 |
0.0001 |
| 518 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
4 |
0.0001 |
| 519 |
HEPATITIS C |
1 |
0.0001 |
| 520 |
PARAESTHESIA |
13 |
0.0001 |
| 521 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 522 |
RESTLESSNESS |
3 |
0.0001 |
| 523 |
DYSPEPSIA |
8 |
0.0001 |
| 524 |
CONFUSIONAL STATE |
13 |
0.0001 |
| 525 |
WEIGHT INCREASED |
18 |
0.0001 |
| 526 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 527 |
DYSPNOEA EXERTIONAL |
3 |
0.0001 |
| 528 |
ASTHMA |
9 |
0.0001 |
| 529 |
BRAIN OEDEMA |
1 |
0.0001 |
| 530 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 531 |
HAEMATEMESIS |
2 |
0.0001 |
| 532 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 533 |
HYPOPHAGIA |
2 |
0.0001 |
| 534 |
ABDOMINAL PAIN UPPER |
16 |
0.0001 |
| 535 |
URTICARIA |
13 |
0.0001 |
| 536 |
HAEMATOMA |
2 |
0.0001 |
| 537 |
AMNESIA |
5 |
0.0001 |
| 538 |
BLOOD CREATININE INCREASED |
5 |
0.0001 |
| 539 |
ADVERSE REACTION |
1 |
0.0001 |
| 540 |
DEHYDRATION |
10 |
0.0001 |
| 541 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 542 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 543 |
JAUNDICE |
2 |
0.0001 |
| 544 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 545 |
TREATMENT NONCOMPLIANCE |
4 |
0.0001 |
| 546 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 547 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 548 |
HEART RATE INCREASED |
7 |
0.0001 |
| 549 |
VOMITING |
33 |
0.0001 |
| 550 |
MOBILITY DECREASED |
5 |
0.0001 |
| 551 |
DRUG INTERACTION |
11 |
0.0001 |
| 552 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 553 |
GASTROENTERITIS |
1 |
0.0001 |
| 554 |
ANGIOEDEMA |
3 |
0.0001 |
| 555 |
COLITIS ULCERATIVE |
3 |
0.0001 |
| 556 |
COLON CANCER |
1 |
0.0001 |
| 557 |
VERTIGO |
4 |
0.0001 |
| 558 |
NASOPHARYNGITIS |
12 |
0.0001 |
| 559 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 560 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 561 |
DECREASED APPETITE |
15 |
0.0001 |
| 562 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 563 |
ASTHENIA |
24 |
0.0001 |
| 564 |
DYSPNOEA |
36 |
0.0001 |
| 565 |
HEAD INJURY |
2 |
0.0001 |
| 566 |
CYSTITIS |
2 |
0.0001 |
| 567 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 568 |
MUSCULAR WEAKNESS |
7 |
0.0001 |
| 569 |
BACK DISORDER |
1 |
0.0001 |
| 570 |
TREATMENT FAILURE |
5 |
0.0001 |
| 571 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 572 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 573 |
FUNGAL INFECTION |
2 |
0.0001 |
| 574 |
HYPOTENSION |
12 |
0.0001 |
| 575 |
FACE OEDEMA |
1 |
0.0001 |
| 576 |
SINUSITIS |
6 |
0.0001 |
| 577 |
SCAR |
1 |
0.0001 |
| 578 |
NAUSEA |
46 |
0.0001 |
| 579 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 580 |
HYPERKALAEMIA |
2 |
0.0001 |
| 581 |
HEART RATE DECREASED |
2 |
0.0001 |
| 582 |
HYPOXIA |
2 |
0.0001 |
| 583 |
HYPERTENSION |
12 |
0.0001 |
| 584 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 585 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 586 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 587 |
DRUG ERUPTION |
1 |
0.0001 |
| 588 |
TOOTHACHE |
1 |
0.0001 |
| 589 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 590 |
PANIC ATTACK |
2 |
0.0001 |
| 591 |
MUSCLE SPASMS |
10 |
0.0001 |
| 592 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 593 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 594 |
FEELING JITTERY |
1 |
0.0001 |
| 595 |
PRODUCT USE IN UNAPPROVED INDICATION |
13 |
0.0001 |
| 596 |
GAIT DISTURBANCE |
10 |
0.0001 |
| 597 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 598 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 599 |
GLAUCOMA |
1 |
0.0001 |
| 600 |
EAR PAIN |
1 |
0.0001 |
| 601 |
ORAL HERPES |
1 |
0.0001 |
| 602 |
ARTHRITIS |
4 |
0.0001 |
| 603 |
PREGNANCY |
1 |
0.0000 |
| 604 |
ILL-DEFINED DISORDER |
3 |
0.0000 |
| 605 |
FEELING HOT |
3 |
0.0000 |
| 606 |
VISUAL IMPAIRMENT |
6 |
0.0000 |
| 607 |
EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 608 |
DERMATITIS |
1 |
0.0000 |
| 609 |
RENAL IMPAIRMENT |
4 |
0.0000 |
| 610 |
MOUTH ULCERATION |
1 |
0.0000 |
| 611 |
TOXICITY TO VARIOUS AGENTS |
8 |
0.0000 |
| 612 |
EATING DISORDER |
1 |
0.0000 |
| 613 |
HYPOAESTHESIA |
7 |
0.0000 |
| 614 |
WEIGHT DECREASED |
13 |
0.0000 |
| 615 |
PSORIASIS |
6 |
0.0000 |
| 616 |
MELAENA |
1 |
0.0000 |
| 617 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 618 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 619 |
MATERNAL EXPOSURE DURING PREGNANCY |
4 |
0.0000 |
| 620 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 621 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 622 |
RASH PAPULAR |
1 |
0.0000 |
| 623 |
SNEEZING |
1 |
0.0000 |
| 624 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 625 |
CHROMATURIA |
1 |
0.0000 |
| 626 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 627 |
NEUTROPENIA |
6 |
0.0000 |
| 628 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 629 |
SHOCK |
1 |
0.0000 |
| 630 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 631 |
RENAL DISORDER |
2 |
0.0000 |
| 632 |
ARRHYTHMIA |
2 |
0.0000 |
| 633 |
MULTIPLE SCLEROSIS |
2 |
0.0000 |
| 634 |
CONTUSION |
4 |
0.0000 |
| 635 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 636 |
PRESYNCOPE |
1 |
0.0000 |
| 637 |
ATRIAL FIBRILLATION |
4 |
0.0000 |
| 638 |
PAIN |
25 |
0.0000 |
| 639 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 640 |
EPISTAXIS |
3 |
0.0000 |
| 641 |
CELLULITIS |
2 |
0.0000 |
| 642 |
HEPATITIS |
1 |
0.0000 |
| 643 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 644 |
RASH |
17 |
0.0000 |
| 645 |
RASH GENERALISED |
1 |
0.0000 |
| 646 |
DEAFNESS |
1 |
0.0000 |
| 647 |
SPEECH DISORDER |
2 |
0.0000 |
| 648 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 649 |
GASTRITIS |
1 |
0.0000 |
| 650 |
CHEST PAIN |
7 |
0.0000 |
| 651 |
CARDIAC FAILURE |
3 |
0.0000 |
| 652 |
DIARRHOEA |
24 |
0.0000 |
| 653 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 654 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 655 |
LIMB INJURY |
1 |
0.0000 |
| 656 |
SKIN LESION |
1 |
0.0000 |
| 657 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 658 |
DIZZINESS |
18 |
0.0000 |
| 659 |
MEDICATION ERROR |
2 |
0.0000 |
| 660 |
DEMENTIA |
1 |
0.0000 |
| 661 |
ANXIETY |
10 |
0.0000 |
| 662 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 663 |
PANCREATIC CARCINOMA |
1 |
0.0000 |
| 664 |
DYSSTASIA |
1 |
0.0000 |
| 665 |
CHILLS |
4 |
0.0000 |
| 666 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 667 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 668 |
ADVERSE DRUG REACTION |
3 |
0.0000 |
| 669 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
0.0000 |
| 670 |
HEPATIC FAILURE |
1 |
0.0000 |
| 671 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 672 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 673 |
ADVERSE EVENT |
3 |
0.0000 |
| 674 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 675 |
DYSPHAGIA |
3 |
0.0000 |
| 676 |
MIGRAINE |
3 |
0.0000 |
| 677 |
ARTHRALGIA |
13 |
0.0000 |
| 678 |
OSTEONECROSIS |
1 |
0.0000 |
| 679 |
VIRAL INFECTION |
1 |
0.0000 |
| 680 |
INSOMNIA |
8 |
0.0000 |
| 681 |
SYNCOPE |
3 |
0.0000 |
| 682 |
OFF LABEL USE |
26 |
0.0000 |
| 683 |
HAEMATURIA |
1 |
0.0000 |
| 684 |
MEMORY IMPAIRMENT |
4 |
0.0000 |
| 685 |
PRURITUS |
11 |
0.0000 |
| 686 |
COUGH |
8 |
0.0000 |
| 687 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 688 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 689 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 690 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 691 |
MALAISE |
12 |
0.0000 |
| 692 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 693 |
DYSURIA |
1 |
0.0000 |
| 694 |
DYSGEUSIA |
2 |
0.0000 |
| 695 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 696 |
DEPRESSION |
6 |
0.0000 |
| 697 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 698 |
PALPITATIONS |
3 |
0.0000 |
| 699 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 700 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 701 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 702 |
FEELING ABNORMAL |
6 |
0.0000 |
| 703 |
FATIGUE |
19 |
0.0000 |
| 704 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 705 |
ERYTHEMA |
5 |
0.0000 |
| 706 |
TREMOR |
4 |
0.0000 |
| 707 |
COMPLETED SUICIDE |
2 |
0.0000 |
| 708 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 709 |
BALANCE DISORDER |
2 |
0.0000 |
| 710 |
MENTAL DISORDER |
1 |
0.0000 |
| 711 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 712 |
RENAL FAILURE |
3 |
0.0000 |
| 713 |
HEADACHE |
14 |
0.0000 |
| 714 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 715 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 716 |
FALL |
7 |
0.0000 |
| 717 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 718 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 719 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 720 |
PAIN IN EXTREMITY |
6 |
0.0000 |
| 721 |
FLUSHING |
2 |
0.0000 |
| 722 |
FLUID RETENTION |
1 |
0.0000 |
| 723 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 724 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 725 |
ILLNESS |
2 |
0.0000 |
| 726 |
NERVOUSNESS |
1 |
0.0000 |
| 727 |
HAEMORRHAGE |
2 |
0.0000 |
| 728 |
PANCREATITIS |
1 |
0.0000 |
| 729 |
RASH PRURITIC |
1 |
0.0000 |
| 730 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 731 |
INFLUENZA |
2 |
0.0000 |
| 732 |
NECK PAIN |
1 |
0.0000 |
| 733 |
FLATULENCE |
1 |
0.0000 |
| 734 |
CONVULSION |
1 |
0.0000 |
| 735 |
HERPES ZOSTER |
1 |
0.0000 |
| 736 |
EYE IRRITATION |
1 |
0.0000 |
| 737 |
SURGERY |
1 |
0.0000 |
| 738 |
PRODUCT DOSE OMISSION ISSUE |
5 |
0.0000 |
| 739 |
DEATH |
14 |
0.0000 |
| 740 |
DRUG INEFFECTIVE |
21 |
0.0000 |
| 741 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 742 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 743 |
SWELLING FACE |
1 |
0.0000 |
| 744 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 745 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 746 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 747 |
BURNING SENSATION |
1 |
0.0000 |
| 748 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 749 |
UNDERDOSE |
1 |
0.0000 |
| 750 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 751 |
ACNE |
1 |
0.0000 |
| 752 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 753 |
BACK PAIN |
3 |
0.0000 |
| 754 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 755 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 756 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 757 |
DRUG ABUSE |
1 |
0.0000 |
| 758 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 759 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 760 |
BREAST CANCER |
1 |
0.0000 |
| 761 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 762 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 763 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 764 |
OVERDOSE |
2 |
0.0000 |
| 765 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 766 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 767 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 768 |
DRY SKIN |
1 |
0.0000 |
| 769 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 770 |
HOSPITALISATION |
1 |
0.0000 |
| 771 |
MYALGIA |
1 |
0.0000 |
| 772 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 773 |
COVID-19 |
1 |
0.0000 |
| 774 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 775 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |